Stock Symbol

688617.SH

About us

ABOUT APT Medical

APT Medical, a leading manufacturer and supplier of EP and Vascular Intervention medical devices, is committed to advancing the interventional medical field utilizing technologies and innovations.


From its inception in 2002, APT is persistent in continuous investment in R&D, which has laid the foundation for its success in the sustainable expansion of technology and growing market share. APT has been collaborating with clinicians, hospitals, and universities to develop innovative products and solutions that empower clinicians to improve patient care.


APT’s growing product portfolio covers Electrophysiology, Cardiology, Peripheral, and Neuro intervention, which constantly brings confidence to clinicians for tackling clinical challenges; with innovation in mind, APT is driven by its vision, to be a leader in the interventional field while protecting the health of humanity.

  • 2002

    Founded in

  • 2021

    Listed in

  • 33%

    CAGR-4 years

  • 89+

    Countries

Culture

  • Sincerity and honesty

    We put sincerity and honesty as the soul of corporation development

  • Enterprising sprite

    Enterprising sprite is the source power of our development. We'll keep moving forward to reach the heights of innovation and development, never be complacent about achievement

  • United

    Be united is the cornerstone of our development. We promote cooperation among our employees and departments, to realize our common goal

  • High efficiency

    High efficiency is the norm of our company development. We emphasize on the executive with the correct attitude and open mind, to form the company culture of target-oriented and mutual achievement

Mr. Cheng Zhenghui

President Message

APT Medical adheres to the principle of providing safer and better quality medical products to help all patients around the world get the most optimized treatment. Most of the design concepts and innovations come from clinical needs to ensure that our products can solve clinical problems and overcome most challenges.


We will successively launch complete EP product solutions, including 3D mapping systems, mapping catheters and ablation catheters; a full range of PCI products in the field of delivery systems. Our products and new solutions to be launched will give doctors more choices to deal with more challenging cases and allow more patients to obtain better medical services at an affordable cost.